The Social Health Authority (SHA) has introduced new changes to cancer treatment approvals in Kenya, a move aimed at standardising treatment costs, improving access to quality healthcare, and protecting patients from unnecessary medical expenses.
In a statement issued on Friday, November 20, 2026, SHA Chief Executive Officer Dr Mercy Mwangangi said the revised system will ensure that cancer patients receive appropriate treatment at standardised rates, in line with the National Cancer Treatment Guidelines.
According to SHA, hospitals have previously charged different prices for similar cancer treatments, leading to significant cost variations across healthcare facilities. In many cases, patients exhausted their allocated medical benefits before completing their prescribed treatment plans.
The authority said the new measures are designed to address these inconsistencies by standardising the pricing and reimbursement of cancer medicines and related medical services. This is expected to promote fairness, transparency, and more efficient use of available healthcare resources.
However, SHA clarified that the changes will not reduce the current cancer treatment benefit, which remains at KSh 800,000 per patient. The benefit consists of KSh 400,000 under the Social Health Insurance Fund (SHIF) and an additional KSh 400,000 under the Emergency, Chronic and Critical Illness Fund (ECCIF).
SHA further revealed that the revised arrangements were developed through extensive consultations coordinated by the Ministry of Health’s National Cancer Control Programme. The discussions involved oncologists, pharmacists, nurses, public and private healthcare providers, and various professional associations.
The authority also cautioned that access to cancer treatment benefits will depend on approved medical guidelines, set tariffs, and eligibility requirements. Treatments and services that fall outside the approved benefits package will not automatically qualify for coverage.
To enhance transparency, hospitals have been directed to clearly explain any additional charges to patients before providing services that are not covered by SHA.
Dr Mwangangi emphasised that patients should not be billed again for medical services that have already been covered and paid for by the authority. She added that any extra costs must be clearly communicated, justified, and aligned with the applicable benefit rules.
The latest changes come at a time when concerns over the affordability of cancer treatment continue to grow in Kenya, with many families struggling to meet the high costs associated with specialised care.
Through the revised system, SHA hopes to improve the management of cancer treatment costs while ensuring that patients make better use of their available medical benefits. The authority believes the changes will help create a more transparent, equitable, and sustainable healthcare system for Kenyans battling cancer.

Leave a Reply